(Alliance News) - Chugai Pharmaceutical Co Ltd on Tuesday announced it has signed an exclusive global license agreement with London-based pharmaceuticals maker GSK PLC. Read More
(Alliance News) - Stocks in London closed in the red on Monday, with fresh gains in the oil price and a lack of new catalysts curbing enthusiasm. Read More
(Alliance News) - Stocks in London closed mixed on Friday, with weak mining and pharmaceutical stocks dragging the blue-chip FTSE 100 lower, but mid-caps posting modest gains. Read More
(Alliance News) - London's FTSE 100 underperformed continental peers on Friday, with software shares rising but impetus lacking elsewhere, leaving the blue-chip benchmark set for a weekly decline. Read More
GSK PLC - London-based pharmaceuticals maker - Global Supply Chain President Regis Simard sells 38,000 shares at GBP20.38 each, for GBP774,440, on Wednesday in London. Read More
(Alliance News) - The FTSE 100 made strong progress on Tuesday, buoyed by positive earnings and a drop in the oil price, which helped shrug off worries sparked by a chip sector sell-off in Asia. Read More
(Alliance News) - GSK PLC on Tuesday said it was planning a cost savings drive to fund investment in late-stage drug development as it reported second quarter results ahead of expectations. Read More
(Alliance News) - GSK PLC on Tuesday notes that licensor Hansoh Pharmaceutical Group Co Ltd has announced positive results from a "pivotal" phase 3 study of risvutatug rezetecan, or Ris-Rez. Read More
(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has approved zidesamtinib, branded as Jideytro, for previously treated ROS1-positive non-small cell lung cancer. Read More
